GAO: FDA yet to make safety changes post-Vioxx
Wednesday, December 9, 2009 - 00:28
in Health & Medicine
WASHINGTON (AP) -- The Food and Drug Administration still hasn't restructured its staff to better monitor drug safety, more than three years after experts recommended key changes in the wake of the Vioxx scandal....